Limba
|
Carfilzomib (PR-171) is an irreversible proteasomeinhibitor with IC50of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagyand induces cell apoptosis.
Price | 2.345,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Carfilzomib (PR-171) is an irreversible proteasomeinhibitor with IC50of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagyand induces cell apoptosis. |